6533b829fe1ef96bd128a374

RESEARCH PRODUCT

Electrospun PHEA-PLA/PCL Scaffold for Vascular Regeneration: A Preliminary in Vivo Evaluation

A. MaffongelliGiuseppe BuscemiSalvatore BuscemiVincenzo Davide PalumboS. FazzottaCalogero FioricaRoberto PuleioFabio Salvatore PalumboGiovanni CassataL. FiorelloMariano LicciardiA.i. Lo Monte

subject

ScaffoldMaterials scienceBiocompatibilityPolymersSwinePolyesters0206 medical engineering02 engineering and technologySettore MED/22 - Chirurgia VascolareNeovascularizationchemistry.chemical_compoundPolylactic acidBlood vessel prosthesismedicineAnimalsTransplantationRegeneration (biology)Bioabsorbable scaffold Bioengineered vascular scaffold Experimental surgery021001 nanoscience & nanotechnology020601 biomedical engineeringBlood Vessel ProsthesisSettore MED/18 - Chirurgia GeneraleCoagulative necrosischemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPolycaprolactoneSurgerymedicine.symptomPeptides0210 nano-technologyBiomedical engineering

description

Abstract Background There is increasing interest in the development of vessel substitutes, and many studies are currently focusing on the development of biodegradable scaffolds capable of fostering vascular regeneration. We tested a new biocompatible and biodegradable material with mechanical properties similar to those of blood vessels. Methods The material used comprises a mixture of α,β-poly(N-2-hydroxyethyl)- d,l -aspartamide (PHEA) and polylactic acid (PLA), combined with polycaprolactone (PCL) by means of electrospinning technique. Low-molecular-weight heparin was also linked to the copolymer. A tubular PHEA-PLA/PCL sample was used to create an arteriovenous fistula in a pig model with the use of the external iliac vessels. The flow was assessed by means of Doppler ultrasound examination weekly, and 1 month after the implantation we removed the scaffold for histopathologic evaluation. Results The implants showed a perfect leak-proof seal and adequate elastic tension to blood pressure. About ∼3 weeks after the implantation, Doppler examination revealed thrombosis of the graft, so we proceeded to its removal. Histologic examination showed chronic inflammation, with the presence of foreign body cells and marked neovascularization. The material had been largely absorbed, leaving some isolated spot residues. Conclusions The biocompatibility of PHEA-PLA/PCL and its physical properties make it suitable for the replacement of vessels. In the future, the possibility of functionalizing the material with a variety of molecules, to modulate the inflammatory and coagulative responses, will allow obtaining devices suitable for the replacement of native vessels.

https://doi.org/10.1016/j.transproceed.2017.02.017